Winner of the call for proposals « Innovations in Biotherapies and Bioproduction for France 2030 », for its anticancer vaccine immunotherapy.
Brenus Pharma announces the financing of nearly 5 million euros for its STC-1010 project as the winner of the « Innovations in Biotherapy and Bioproduction » call for proposals from France 2030. Operated on behalf of the French government by Bpifrance, this support aims to catalyze and maintain excellence in biotherapy research and places Brenus Pharma among the key players of French Biotherapy.